The market expects Iovance Biotherapeutics (IOVA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

Iovance Biotherapeutics, Inc, a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic ...

In our first Black History Monday spotlight is Dr. Dalton Miller-Jones, a retired Portland State University professor emeritus. Born and raised in the South in the 1940s to parents Clarence and ...

IOVA opened at $5.78 on Friday. The company’s 50 day simple moving average is $6.44 and its 200 day simple moving average is $8.71. Iovance Biotherapeutics has a 1 year low of $5.05 and a 1 year ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Want to know the Dr. Stone season 4, episode 10 release date? It could be an important one, as we anticipate it's the anime's final episode until it goes on a short break. Below, we've got the ...

SAN CARLOS, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, ...